Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures

Abstract

Objective:

Compare neurodevelopment after levetiracetam (LEV) and phenobarbital (PB) for neonatal seizures.

Study design:

Retrospective study of infants who received antiepileptic drugs (AEDs) for neonatal seizures. Effect of cumulative exposure to LEV and PB on outcomes of death, cerebral palsy (CP) and Bayley Scales of Infant Development (BSID) scores were evaluated at 24 months corrected age. Analyses were adjusted for number of electrographic seizures and gestational age.

Result:

In 280 infants with comparable seizure etiology and cranial imaging results, increased exposure to PB was associated with worse BSID cognitive and motor scores (8.1- and 9-point decrease per 100 mg kg−1; P=0.01). The effect was less with LEV (2.2- and 2.6-point decrease per 300 mg kg−1 LEV (P=0.01)). CP probability increased by 2.3-fold per 100 mg kg−1 PB and was not associated with increasing LEV.

Conclusion:

Increased exposure to PB is associated with worse neurodevelopmental outcomes than LEV. Prospective studies of outcomes of neonatal exposure to AEDs are essential.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

References

  1. Moster D, Wilcox AJ, Vollset SE, Markestad T, Lie RT . Cerebral palsy among term and postterm births. JAMA 2010; 304 (9): 976–982.

    Article  CAS  Google Scholar 

  2. Saigal S, Doyle LW . An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008; 371 (9608): 261–269.

    Article  Google Scholar 

  3. Yeargin-Allsopp M, Van Naarden Braun K, Doernberg NS, Benedict RE, Kirby RS, Durkin MS . Prevalence of cerebral palsy in 8-year-old children in three areas of the United States in 2002: a multisite collaboration. Pediatrics 2008; 121 (3): 547–554.

    Article  Google Scholar 

  4. Perez A, Ritter S, Brotschi B, Werner H, Caflisch J, Martin E et al. Long-term neurodevelopmental outcome with hypoxic-ischemic encephalopathy. Journal of Pediatrics 2013; 163 (2): 454–459.

    Article  Google Scholar 

  5. Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, Gaynor JW et al. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation 2012; 126: 1143–1172.

    Article  Google Scholar 

  6. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004; 292 (19): 2357–2365.

    Article  CAS  Google Scholar 

  7. Long A, Moran P, Robson S . Outcome of fetal cerebral posterior fossa anomalies. Prenat Diagn 2006; 26 (8): 707–710.

    Article  Google Scholar 

  8. Gillam-Krakauer M, Carter BS . Neonatal hypoxia and seizures. Pediatr Rev 2012; 33 (9): 387–397.

    Article  Google Scholar 

  9. Sivaswamy L . Approach to neonatal seizures. Clin Pediatr (Phila) 2012; 51 (5): 415–425.

    Article  Google Scholar 

  10. van Rooij LGM, Hellstrom-Westas L, de Vries LS . Treatment of neonatal seizures. Semin Fetal Neonatal Med 2013; 18 (4): 1–7.

    Article  Google Scholar 

  11. Cilio MR, Ferriero DM . Synergistic neuroprotective therapies with hypothermia. Semin Fetal Neonatal Med [Internet]. 2010; 15 (5): 293–298.

    Article  Google Scholar 

  12. Painter MJ, Scher MS, Stein AD, Armatti S, Wang Z, Gardiner JC et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med 1999; 341 (7): 485–489.

    Article  CAS  Google Scholar 

  13. Castro Conde JR, Hernández Borges AA, Doménech Martínez E, González Campo C, Perera Soler R . Midazolam in neonatal seizures with no response to phenobarbital. Neurology 2005; 64 (5): 876–879.

    Article  CAS  Google Scholar 

  14. Löscher W, Rogawski MA . How theories evolved concerning the mechanism of action of barbiturates. Epilepsia 2012; 53 (Suppl 8): 12–25.

    Article  Google Scholar 

  15. Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D, Govindarajalu S et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA 2002; 99 (23): 15089–15094.

    Article  CAS  Google Scholar 

  16. Sulzbacher S, Farwell JR, Temkin N, Lu AS, Hirtz DG . Late cognitive effects of early treatment with phenobarbital. Clin Pediatr (Phila) 1999; 38 (7): 387–394.

    Article  CAS  Google Scholar 

  17. Farwell JR, Lee YJ, Hirtz DG, Sulzbacher SI, Ellenberg JH, Nelson KB . Phenobarbital for febrile seizures—effects on intelligence and on seizure recurrence. N Engl J Med 1990; 322 (6): 364–369.

    Article  CAS  Google Scholar 

  18. Park S-P, Kwon S-H . Cognitive Effects of Antiepileptic Drugs. J Clin Neurol 2008; 4 (3): 99.

    Article  Google Scholar 

  19. Abend NS, Gutierrez-Colina AM, Monk HM, Dlugos DJ, Clancy RR . Levetiracetam for treatment of neonatal seizures. J Child Neurol 2011; 26 (4): 465–470.

    Article  Google Scholar 

  20. Ramantani G, Ikonomidou C, Walter B, Rating D, Dinger J . Levetiracetam: Safety and efficacy in neonatal seizures. Eur J Paediatr Neurol 2011; 15 (1): 1–7.

    Article  Google Scholar 

  21. Silverstein FS, Ferriero DM . Off-label use of antiepileptic drugs for the treatment of neonatal seizures. Pediatr Neurol 2008; 39 (2): 77–79.

    Article  Google Scholar 

  22. Lee C-Y, Chen C-C, Liou H-H . Levetiracetam inhibits glutamate transmission through presynaptic P/Q-type calcium channels on the granule cells of the dentate gyrus. Br J Pharmacol 2009; 158 (7): 1753–1762.

    Article  CAS  Google Scholar 

  23. Yan H-D, Ishihara K, Seki T, Hanaya R, Kurisu K, Arita K et al. Inhibitory effects of levetiracetam on the high-voltage-activated L-type Ca2+ channels in hippocampal CA3 neurons of spontaneously epileptic rat (SER). Brain Res Bull 2013; 90: 142–148.

    Article  CAS  Google Scholar 

  24. Yang X-F, Weisenfeld A, Rothman SM . Prolonged exposure to levetiracetam reveals a presynaptic effect on neurotransmission. Epilepsia 2007; 48 (10): 1861–1869.

    Article  CAS  Google Scholar 

  25. Meehan AL, Yang X, Yuan L-L, Rothman SM . Levetiracetam has an activity-dependent effect on inhibitory transmission. Epilepsia 2012; 53 (3): 469–476.

    Article  CAS  Google Scholar 

  26. Brunquell PJ, Glennon CM, DiMario FJ, Lerer T, Eisenfeld L . Prediction of outcome based on clinical seizure type in newborn infants. Pediatr 2002; 140 (6): 707–712.

    Article  Google Scholar 

  27. Voress JMT . Developmental Assessment of Young Children. PRO-ED: Austin, TX, 1998.

    Google Scholar 

  28. Albers C GA . Test review: Bayley Scales of Infant and Toddler Development, Third Edition. J Psychoeduc Assess 2007; 25 (2): 180–190.

    Article  Google Scholar 

  29. Kuban K, Allred E, O'Shea M, Paneth N, Pagano M, Leviton A . An algorithm for identifying and classifying cerebral palsy in young children. J Pediatr. 2008 153 4: 466–472.

    Google Scholar 

  30. Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl 2007; 109: 8–14.

    PubMed  Google Scholar 

  31. Palisano RJ, Rosenbaum P, Bartlett D, Livingston MH . Content validity of the expanded and revised Gross Motor Function Classification System. Dev Med Child Neurol 2008; 50 (10): 744–750.

    Article  Google Scholar 

  32. Kim J-S, Kondratyev A, Tomita Y, Gale K . Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain. Epilepsia 2007; 48 (s5): 19–26.

    Article  CAS  Google Scholar 

  33. Forcelli PA, Janssen MJ, Vicini S, Gale K . Neonatal exposure to antiepileptic drugs disrupts striatal synaptic development. Ann Neurol 2012; 72 (3): 363–372.

    Article  CAS  Google Scholar 

  34. Shankaran S . Neurodevelopmental outcome of premature infants after antenatal phenobarbital exposure. Am J Obstet Gynecol 2002; 187 (1): 171–177.

    Article  Google Scholar 

  35. Shankaran S, Papile LA, Wright LL, Ehrenkranz RA, Mele L, Lemons JA et al. The effect of antenatal phenobarbital therapy on neonatal intracranial hemorrhage in preterm infants. N Engl J Med 2000; 337 (7): 466–471.

    Article  Google Scholar 

  36. Ries M . Cognitive effects of “older” anticonvulsants in children with epilepsy: a review and critique of the literature. J Pediatr Pharmacol Ther 2003; 8 (2): 115–131.

    PubMed  PubMed Central  Google Scholar 

  37. Kilicdag H, Daglıoglu K, Erdogan S, Guzel A, Sencar L, Polat S et al. The effect of levetiracetam on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury. Early Hum Dev 2013; 89 (5): 355–360.

    Article  CAS  Google Scholar 

  38. Stienen MN, Haghikia A, Dambach H, Thöne J, Wiemann M, Gold R et al. Anti-inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia are mediated via TGFβ1 regulation. Br J Pharmacol 2010; 162 (2): 491–507.

    Article  Google Scholar 

  39. Talos DM, Chang M, Kosaras B, Fitzgerald E, Murphy A, Folkerth RD et al. Antiepileptic effects of levetiracetam in a rodent neonatal seizure model. Pediatr Res 2012; 73 (1): 24–30.

    Article  Google Scholar 

  40. Shallcross R, Bromley RL, Irwin B, Bonnett LJ, Morrow J, Baker GA et al. Child development following in utero exposure: levetiracetam vs sodium valproate. Neurology 2011; 76 (4): 383–389.

    Article  CAS  Google Scholar 

  41. Tulloch JK, Carr RR, Ensom MHH . A systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures. J Pediatr Pharmacol Ther 2012; 17 (1): 31–44.

    PubMed  PubMed Central  Google Scholar 

  42. Merhar SL, Schibler KR, Sherwin CM, Meinzen-Derr J, Shi J, Balmakund T et al. Pharmacokinetics of levetiracetam in neonates with seizures. J Pediatr 2011; 159 (1): 152–153.

    Article  CAS  Google Scholar 

  43. Cormier J, Chu CJ . Safety and efficacy of levetiracetam for the treatment of partial onset seizures in children from one month of age. Neuropsychiatr Dis Treat 2013; 9: 295.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Khan O, Chang E, Cipriani C, Wright C, Crisp E, Kirmani B . Use of intravenous levetiracetam for management of acute seizures in neonates. Pediatr Neurol 2011; 44 (4): 265–269.

    Article  Google Scholar 

  45. Oztekin O, Kalay S, Tezel G, Akcakus M, Oygur N . Can we safely administer the recommended dose of phenobarbital in very low birth weight infants? Childs Nerv Syst 2013; 29 (8): 1353–1357.

    Article  Google Scholar 

  46. Touw DJ, Graafland O, Cranendonk A, Vermeulen RJ, Van Weissenbruch MM . Clinical pharmacokinetics of phenobarbital in neonates. Eur J Pharm Sci 2000; 12 (2): 111–116.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Matthew Marshall for programming the data extraction from the pharmacy database. Study data were collected and managed using REDCap electronic data capture tools hosted at Vanderbilt University, supported by grant 1 UL1 RR024975 from NCRR/NIH.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N L Maitre.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Journal of Perinatology website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maitre, N., Smolinsky, C., Slaughter, J. et al. Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures. J Perinatol 33, 841–846 (2013). https://doi.org/10.1038/jp.2013.116

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2013.116

Keywords

This article is cited by

Search

Quick links